A new benzenoid, 4-methoxy-7-methylbenzo [d] [1, 3]dioxol-5-ol (1) and three known secondary metabolites 2,3-dimethoxy-5-methyl[1,4]benzoquinone (2), 2-methoxy-6-methyl-1,4-benzoquinone (3) and 5-methyl-benzo[1,3]dioxole-4,7-diol (4) were isolated from the mycelia of A. cinnamomea BCRC 36799 by solid state fermentation with adlay. Their chemical structures were elucidated on the basis of HRESIMS, NMR spectroscopic data and comparison with reported values. All isolated compounds 1-4 were tested for their cytotoxicity against the six cancer cell lines using the MTT assay. Among them, compound 3 displayed significant cytotoxic effects toward all six tested cancer cell lines, with IC 50 values ranging from 2.8-8.7 µM in vitro.
Antrodia cinnamomea
is an exclusion fungus parasitic on the inner wall of the endemic and endangered species Cinnamomum kanehirai Hay in Taiwan [1] . The fruiting bodies of Antrodia cinnamomea, which are called "chang-chih" or "niu chang ku" in Taiwan, are used for the treatment of food, alcohol and drug intoxication, diarrhea, abdominal pain, hypertension, itchy skin and liver cancer in Taiwanese folk medicine. The pharmacological effects of mycelia from submerged cultivations of Antrodia cinnamomea include antiinflammatory [2] , anticancer properties [3] and anti-hepatitis B virus activities [4a] . In this paper, we present the isolation and structure elucidation of one new benzenoid 1 (Figure 1 ), together with three known compounds from the mycelia of A. cinnamomea was produced by solid state fermentation with adlay.
Compound 1 was assigned C 9 H 10 O 4 based on HREIMS data (m/z at 182.0586, Calcd 182.0579). The IR spectrum suggested that 1 was an aromatic compound (1634 and 1503 cm -1 ) with a hydroxy group (3415 cm -1 ). The 1 H NMR spectrum of 1 showed a methylenedioxy moiety (δ H 5.76, 2H, s, H-2), a methoxy group (δ H 3.72, 3H, s, OCH 3 -4), and a methyl group (δ H 2.06, 3H, s, CH 3 -7) and a singlet aromatic proton [δ H 6.14 (1H, s, H-6)]. On the other hand, no detectable NOESY effect could be observed between OCH 3 and H-6, and thus, the OH and OCH 3 at C-5 and C-4 were confirmed. The correlation of CH 3 -7/H-4 was also observed in the NOESY experiment ( Figure 1 ) and further supported the position of each aromatic substitution. In the HMBC spectrum (Figure 1 ), the significant correlations between δ H 2.06 (CH 3 -7) and δ C 109.5 (C-7)/142.1 (C-8), δ H 3.72 (OCH 3 -4) and δ C 135.2 (C-4), δ H 5.76 (H-2) and δ C 136.4 (C-9)/142.1 (C-8), as well as δ H 6.14 (H-6) and δ C 135.2 (C-4)/147.0 (C-5), suggested that the substitutes Me, OH, OCH 3 and -OCH 2 O-were connected to C-7, C-5, C-4 and C-8/9 of the benzene moiety, respectively. These data, supported by the 13 C NMR, DEPT, COSY, HSQC and HMBC ( Figure 1 ) spectra, were in agreement with a benzene system bearing one methylenedioxy moiety [4b]. The structure was established as 4-methoxy-7-methylbenzo[d] [1, 3] dioxol-5-ol. The other known isolates, 2,3-dimethoxy-5-methyl [1, 4] benzoquinone (2) [5a], 2-methoxy-6-methyl-1,4-benzoquinone (3) [5a] and 5-methyl-benzo [1, 3] dioxole-4,7-diol (4) [6] were identified by comparison of spectral data. Briefly, BCRC 36799 was plated onto PDA plates and cultivated at 25°C for 21 days. The plate was homogenized with 100 mL sterile water for the preparation of inoculums. Inoculums (100 mL) were inoculated into 2L shake flasks containing 750 mL PDB medium and cultivated with shaking (100 rpm) at 25C for 7 days to obtain the mycelial broth. Twenty 450-mL glass bottles, each containing 50 g adlay and 50 mL D.I. water, were sterilized for 20 min at 121°C. The mycelial broth (5 ml) was added to each bottle and cultivated at 25°C for 21 days. The resultant A. cinnamomea adlay products were harvested together into plastic (or stainless steel) tank and immersing in 95% ethanol for further purification.
Extraction and separation:
The adlay of A. cinnamomea BCRC 36799 (1 kg) was extracted three times with 95 % EtOH (2.0 L) at r.t.. Then, the crude ethanol extract was evaporated under reduced pressure and partitioned between EtOAc/H 2 O (1:1, v/v) to give EtOAc and H 2 O soluble fractions. The EtOAc-soluble fraction (29.3 g) was chromatographed by SiO 2 CC (70-230 mesh), eluting with n-hexane, EtOAc and MeOH of increasing polarity to obtain 13 fractions. Fr.4 was purified by preparative TLC (n-hexane: acetone, 6:1) to furnish 2 (3.2 mg) and 3 (4.2mg). Fr.6 was purified by preparative TLC (n-hexane/acetone, 1:1) to yield 4 (5.2 mg). Fr. 7 was further purified by CC (45 g SiO 2 , 70-230 mesh), eluting with n-hexane and enriched with acetone to yield 7 subfractions: Fr. 7.1-7.7. The fraction 7.5 was further separated by semipreparative HPLC with 50% MeOH on an Inertsil ODS-3 semi-preparetive column (250 x 10.0 mm i.d., 5 μm) to obtain 1 (4.6 mg).
Cytotoxicity Assay: The six cell lines were MCF-7 human breast adenocarcinoma, MDA-MB-453 human breast carcinoma, A-549 human lung carcinoma, DU145 human prostate carcinoma, LNCap human prostate carcinoma and HepG2 human hepatoblastoma. All cell lines were acquired from Bioresource Collection and Research Center (BCRC, FIRDI, Hsinchu, Taiwan). Cells were grown in the recommended culture medium at 37°C in 5% CO 2 . Cells were seeded in 96-well tissue culture plates. To account for intrinsic differences in growth rate, the HepG2 and DU145 lines were plated at 3,000 cells per well, MCF-7 at 3,500 per well, A-549 and LNCaP at 5,000 per well, and MDA-MB-453 at 8,000 per well. After 24 hours the test compounds were added and incubated for 48 hours. To determine cell viability the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay was used. The MTT colorimetric assay was modified from that reported by Mosman [5b] . Test is based upon the selective ability of living cells to reduce the yellow soluble salt, MTT, to a purple-blue insoluble formazan MTT solution (Merck, dissolved in phosphate-buffered saline at 5 mg/ml). MTT solution was added into the attached cells mentioned above (20 μL per 200 μL culture) and incubated at 37 °C for 4 hours. After that 100 μL DMSO was added and amount of colored formazan metabolite formed was determined by measuring of the absorbance at 550 nm. The optical density of formazan formed in control (untreated) cells was taken as 100% viability. 
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